Title |
Vestibular migraine: the most frequent entity of episodic vertigo
|
---|---|
Published in |
Journal of Neurology, April 2016
|
DOI | 10.1007/s00415-015-7905-2 |
Pubmed ID | |
Authors |
Marianne Dieterich, Mark Obermann, Nese Celebisoy |
Abstract |
Vestibular migraine (VM) is the most common cause of episodic vertigo in adults as well as in children. The diagnostic criteria of the consensus document of the International Bárány Society for Neuro-Otology and the International Headache Society (2012) combine the typical signs and symptoms of migraine with the vestibular symptoms lasting 5 min to 72 h and exclusion criteria. Although VM accounts for 7 % of patients seen in dizziness clinics and 9 % of patients seen in headache clinics it is still underdiagnosed. This review provides an actual overview on the pathophysiology, the clinical characteristics to establish the diagnosis, the differential diagnosis, and the treatment of VM. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 36% |
United Kingdom | 2 | 14% |
Australia | 1 | 7% |
Japan | 1 | 7% |
Germany | 1 | 7% |
Unknown | 4 | 29% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 9 | 64% |
Practitioners (doctors, other healthcare professionals) | 4 | 29% |
Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Pakistan | 1 | <1% |
Australia | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 293 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 33 | 11% |
Other | 31 | 10% |
Researcher | 31 | 10% |
Student > Postgraduate | 28 | 9% |
Student > Bachelor | 25 | 8% |
Other | 65 | 22% |
Unknown | 83 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 120 | 41% |
Neuroscience | 31 | 10% |
Nursing and Health Professions | 26 | 9% |
Biochemistry, Genetics and Molecular Biology | 4 | 1% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 1% |
Other | 16 | 5% |
Unknown | 95 | 32% |